Clinical trial
Multicenter Double-blind Placebo-Controlled Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children
NCT03159104 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Double-blind Placebo-Controlled Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children
- Lead sponsor
- Materia Medica Holding
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 25, 2015
- Completion date
- February 18, 2019
- Enrollment
- 240 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
specific developmental disorders of scholastic skills